Adam Wellikoff is a Respiratory physician affiliated with John F. Kennedy Medical Center. OpenAlex indexes 28 publications with 249 citations (h-index 3); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
190 John F Kennedy Dr
Atlantis, FL 334621186
Telephone
561-967-4118Provider last certified this registry record 23 Mar 2026.
Clinical trials
- Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung
Sponsor: Mauna Kea Technologies
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202512 payments
- GlaxoSmithKline, LLC.Program year202517 payments
- Grifols USA, LLCProgram year202517 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
68.6%Corticosteroid36.4%Trelegy Ellipta63%Breo Ellipta13%Breztri Aerosphere13%Symbicort5%Arnuity Ellipta4%Fluticasone Propionate2%Part D<11 patientsbeta2-Adrenergic Agonist21.1%Albuterol Sulfate Hfa96%Ventolin Hfa4%Part D≥177 patients+ 5 more classes in this area
Metabolism & gastrointestinal
15.5%Corticosteroid15.5%Prednisone100%Part D≥191 patientsAnti-infectives
11.2%Macrolide Antimicrobial4.6%Azithromycin100%Part D≥55 patientsTetracycline-class Drug4.5%Doxycycline Hyclate100%Part D≥77 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial
American Journal of Respiratory and Critical Care Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Borzak, MD
John F. Kennedy Medical Center
Peter Polos, MD
John F. Kennedy Medical Center
Juliet Ray, MD
John F. Kennedy Medical Center
Robert Fishel, MD
John F. Kennedy Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”